Clinical Trials

A Phase IB Trial Of Neoadjuvant AMG 232 Concurrent With Preoperative Radiotherapy In Wild-Type P53 Soft Tissue Sarcoma (STS)


Study ID
NRG Oncology NRG-DT001

NCT Number
NCT03217266 (Click on the NCT number for more information about the trial)

Research Study Number
2019-0035

Principle Investigator
Dr. Andrew Pecora

Phase
I

Sponsor
NRG Oncology


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now